-
1 month ago | 
cannabislaw.report | Hillary Chinigo Campbell |Whitt Steineker
It’s funny how things work out – sometimes you find yourself living in a sort of butterfly effect where the tail seems to wag the dog. In 2023, when we first started writing about the traction psychedelics were gaining as medicine, our goal was not to end up spending years covering the winding legal battle of a Washington physician to legally obtain psilocybin for terminally ill cancer patients to manage their pain. But here we are.
-
1 month ago | 
jdsupra.com | Hillary Chinigo Campbell |Whitt Steineker
It’s funny how things work out – sometimes you find yourself living in a sort of butterfly effect where the tail seems to wag the dog. In 2023, when we first started writing about the traction psychedelics were gaining as medicine, our goal was not to end up spending years covering the winding legal battle of a Washington physician to legally obtain psilocybin for terminally ill cancer patients to manage their pain. But here we are.
-
1 month ago | 
lexology.com | Hillary Chinigo Campbell |Whitt Steineker
It’s funny how things work out – sometimes you find yourself living in a sort of butterfly effect where the tail seems to wag the dog. In 2023, when we first started writing about the traction psychedelics were gaining as medicine, our goal was not to end up spending years covering the winding legal battle of a Washington physician to legally obtain psilocybin for terminally ill cancer patients to manage their pain. But here we are.
-
Oct 3, 2024 | 
cannabislaw.report | Hillary Chinigo Campbell
Cannabis consumers can be forgiven for feeling the need for a more liberal cannabis policy as they weather this seemingly unending campaign cycle. Republican presidential candidate Donald Trump recently made clear how he would be voting personally on the legalization of the recreational use of marijuana. Posting on Truth Social, Trump stated:As a Floridian, I will be voting YES on Amendment 3 this November.
-
Oct 1, 2024 | 
jdsupra.com | Hillary Chinigo Campbell |Whitt Steineker
Cannabis consumers can be forgiven for feeling the need for a more liberal cannabis policy as they weather this seemingly unending campaign cycle. Republican presidential candidate Donald Trump recently made clear how he would be voting personally on the legalization of the recreational use of marijuana. Posting on Truth Social, Trump stated:As a Floridian, I will be voting YES on Amendment 3 this November.
-
Oct 1, 2024 | 
natlawreview.com | Hillary Chinigo Campbell
Cannabis consumers can be forgiven for feeling the need for a more liberal cannabis policy as they weather this seemingly unending campaign cycle. Republican presidential candidate Donald Trump recently made clear how he would be voting personally on the legalization of the recreational use of marijuana. Posting on Truth Social, Trump stated:As a Floridian, I will be voting YES on Amendment 3 this November.
-
Oct 1, 2024 | 
practicesource.com | Hillary Chinigo Campbell |Whitt Steineker
Welcome to the Practice Source & House of Butter’s Global Law Blogs directory. At PracticeSource.com and The House of Butter Blog we have been writing about lawyers, legal publishing and legal information on a daily basis for over 20 years. We have decided to compile what we think, are, the best law / legal blogs written across language by lawyers, barristers & law firm (teams) from around the world. https://lawblogs.practicesource.com/
-
Aug 27, 2024 | 
jdsupra.com | Hillary Chinigo Campbell |Whitt Steineker
We at Budding Trends have been optimistic, and then cautiously optimistic, that the legalization of psychedelics was close. This month, however, the U.S. Food and Drug Administration dealt a blow to our predictions. FDA decided not to approve Lykos Therapeutics, Inc.’s MDMA-assisted PTSD therapy at this time. Instead, FDA asked Lykos to further study the efficacy of the treatment. More specifically, FDA asked Lykos to conduct another Phase 3 trial to determine the drug’s efficacy and safety.
-
Aug 27, 2024 | 
cannabislaw.report | Hillary Chinigo Campbell |Whitt Steineker
We at Budding Trends have been optimistic, and then cautiously optimistic, that the legalization of psychedelics was close. This month, however, the U.S. Food and Drug Administration dealt a blow to our predictions. FDA decided not to approve Lykos Therapeutics, Inc.’s MDMA-assisted PTSD therapy at this time. Instead, FDA asked Lykos to further study the efficacy of the treatment. More specifically, FDA asked Lykos to conduct another Phase 3 trial to determine the drug’s efficacy and safety.
-
Aug 26, 2024 | 
natlawreview.com | Hillary Chinigo Campbell
We at Budding Trends have been optimistic, and then cautiously optimistic, that the legalization of psychedelics was close. This month, however, the U.S. Food and Drug Administration dealt a blow to our predictions. FDA decided not to approve Lykos Therapeutics, Inc.’s MDMA-assisted PTSD therapy at this time. Instead, FDA asked Lykos to further study the efficacy of the treatment. More specifically, FDA asked Lykos to conduct another Phase 3 trial to determine the drug’s efficacy and safety.
